Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia

A 50-year-old male with chronic lymphocytic leukemia (CLL) was treated with fludarabine, cyclophosphamide and rituximab, which produced a complete remission. Eight months after the last dose of rituximab he had visual disturbance, diminished muscular strength in the right arm and vesicular-papular l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Exp Hematol Oncol
Egile Nagusiak: Garrote, Heidys, de la Fuente, Adolfo, Oña, Raquel, Rodríguez, Inmaculada, Echevarría, Juan E, Sepúlveda, Juan M, García, Juan F
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4357158/
https://ncbi.nlm.nih.gov/pubmed/25767742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0003-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak